Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-11

Clinical Trial Update: Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating intensity-modulated radiation therapy with etoposide and cyclophosphamide followed by donor stem cell transplantation in relapsed o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Etoposide (Etoposide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-11